Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

AGNC Investment Is Joining the S&P MidCap 400 Index. Here's What That Means for Its 14%+ Yield.

AGNC Investment, a mortgage REIT, joined the S&P MidCap 400 Index on September 21, 2026. While index inclusion will increase institutional ownership through passive funds and ETFs, it won't directly impact the REIT's monthly dividend of $0.12 per share. The company's 14.6% yield reflects a 20% share price decline this year due to rising interest rates. AGNC's dividend sustainability depends on maintaining returns above its cost of capital, currently in the 15-17% range.

AGNC Investment To Be Added To S&P MidCap 400 Index, Effective September 21

AGNC Investment Corp. (NASDAQ:AGNC) ("AGNC" or the "Company") announced today that it will be added to the S&P MidCap 400 Index, effective prior to the open of trading on Monday, September 21, 2026.

If Zero Rates Are Gone for Good, What Is a Checking Account Worth to a Bank?

As interest rates rise, checking accounts become increasingly valuable to banks like Bank of America because they represent the lowest-cost source of capital available. Unlike mortgage REITs that are subject to market rates, banks have control over deposit rates and can maintain profitable spreads between borrowing and lending costs. The stickiness of customer relationships and switching costs further enhance the value of checking accounts in a higher-rate environment.

10-Year Treasuries Yield About 4.8%. Here Are 3 High-Yielding Dividend Stocks That Actually Beat That.

With 10-year Treasury yields at 4.8%, three dividend stocks offer higher yields and additional upside potential: AGNC Investment with a 13.5% yield benefits from favorable MBS spread conditions; Energy Transfer offers 6.3% yield with strong growth prospects in midstream infrastructure and AI data center demand; and Verizon provides 5.6% yield with improving subscriber metrics and fiber network expansion opportunities.

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Arcutis Biotherapeutics announced the grant of 57,000 restricted stock units (RSUs) to 11 newly hired employees as a material inducement for employment. The RSUs will vest over four years with 25% vesting annually, subject to continued employment. The company also announced that management will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14-16, 2026.

Shares of data center infrastructure-related companies are trading higher amid multiple catalysts including optimism connected to demand for Meta's Muse AI agent and Akamai's seven-year, $11.6 billion cloud services agreement from Anthropic, both of which help underpin demand for physical compute space.